First Community Finl (FCMP) 5.8400 $FCMP First Community

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
First Community Finl (FCMP) 5.8400 $FCMP

First Community Financial Partners, Inc. Announces First Quarter 2015 Financial Results
GlobeNewswire - Wed Apr 22, 5:27PM CDT
First Community Financial Partners, Inc. (OTCQB:FCMP) ("First Community" or the "Company", the parent company of First Community Financial Bank (the "Bank", today reported financial results for the three month period ended March 31, 2015.

First Community Financial Partners, Inc. Reports Net Income Applicable to Common Shareholders of $5.4 Million for the Year Ended December 31, 2014
GlobeNewswire - Wed Jan 21, 4:05PM CST
First Community Financial Partners, Inc. (OTCQB:FCMP) ("First Community", the parent company of First Community Financial Bank (the "Bank", today reported that its net income applicable to common shareholders for the three months ended December 31, 2014, was $1.8 million, or $0.11 per diluted share, which was flat when compared with the results of $1.9 million, or $0.11 per diluted share, for the three months ended September 30, 2014. Net income applicable to common shareholders for the year ended December 31, 2014, was $5.4 million, or $0.32 per diluted share, compared with $20.6 million, or $1.29 per diluted share, for the year ended December 31, 2013. The results for 2013 included an income tax benefit of $14.6 million primarily related to the reversal of a previously established deferred tax valuation allowance and $4.9 million related to gains on redemption of preferred stock. Income before income taxes was $8.6 million for the year ended December 31, 2014, as compared to $2.1 million for the year ended December 31, 2013.

First Community Financial Partners, Inc. Completes Repurchase of $6.3 Million of Preferred Stock
GlobeNewswire - Tue Dec 09, 3:30PM CST
First Community Financial Partners, Inc. (OTCQB:FCMP) ("First Community", repurchased all of its remaining outstanding shares of Fixed Rate Cumulative Perpetual Preferred Stock, Series B (the "Series B Preferred Stock", and Fixed Rate Cumulative Perpetual Preferred Stock, Series C (the "Series C Preferred Stock", that were originally issued to the U.S. Department of the Treasury under the Troubled Asset Relief Program Capital Purchase Program ("TARP". 5,176 shares of Series B Preferred Stock and 1,100 shares of Series C Preferred Stock, with a liquidation preference of $1,000 per share, were repurchased from certain third-party investors at an aggregate purchase price of $6.3 million. The proceeds from First Community's 7.0% subordinated debt raise that closed on October 31, 2014 were used to fund the repurchase of the preferred stock. With the Series B Preferred Stock dividend rate increasing from 5% to 9% in 2015, the repurchase of the preferred stock will result in an estimated annual savings of $301,000, due to the elimination of payment of dividends on the repurchased shares. "The retirement of the preferred stock eliminates the remnants of TARP," said Roy C. Thygesen, CEO. "We are pleased to put closure to this chapter and to continue enhancing our returns to common shareholders."

First Community Financial Partners, Inc. Reports Net Income of $3.5 million, or $0.21 per Diluted Share, for the Nine Months Ended September 30, 2014
GlobeNewswire - Tue Oct 21, 4:08PM CDT
First Community Financial Partners, Inc. (OTCQB:FCMP) ("First Community", the parent company of First Community Financial Bank (the "Bank", today reported that its net income applicable to common shareholders for the three months ended September 30, 2014 rose to $1.9 million, or $0.11 per diluted share, compared with $1.3 million, or $0.08 per diluted share, for the three months ended June 30, 2014.

First Community Financial Partners, Inc. Reports a 57.24% Reduction in Nonperforming Assets for the Twelve Months Ended June 30, 2014
GlobeNewswire - Tue Jul 22, 3:59PM CDT
First Community Financial Partners, Inc. (OTCQB:FCMP) ("First Community", the parent company of First Community Financial Bank (the "Bank", today reported that its net income applicable to common shareholders for the three months ended June 30, 2014 was $1.3 million, or $0.08 per diluted share, compared with $567,000, or $0.03 per diluted share, for the three months ended June 30, 2013.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Eco Wave Power Expands Wave Energy Project in Europe

Updated Category News Views 229

Eco Wave Power Initiates Key Infrastructure Enhancements Eco Wave Power Global AB (publ) (NASDAQ: WAVE) is excited to unveil plans for crucial upgrades at its groundbreaking wave energy project. This groundbreaking initiative is set to harness ocean wave energy to produce clean electricity efficiently. Eco Wave Power, recognized as a leading company in onshore wave energy...

Continue Reading
Key Managerial Transactions Reported by Danske Bank A/S

Updated Category News Views 162

Recent Mandatory Transaction Notifications by Danske Bank A/S Danske Bank A/S is committed to transparency in financial transactions involving its managerial personnel. This communication signifies the bank's adherence to the EU Market Abuse Regulation and the requirements set by the Danish Financial Supervisory Authority (FSA) and Nasdaq Copenhagen. Understanding...

Continue Reading
Strategic Insights into Symbotic's Options Market Activity

Updated Category News Views 187

Overview of Options Activity for Symbotic Recently, significant investors have demonstrated a notably bearish outlook on Symbotic. This trend has been evidenced by the options activity surrounding the company's stock, symbolized by SYM. The strong presence of whales entering the market indicates a shift in investor sentiment, with nuances that are crucial for...

Continue Reading
South Coast AQMD Takes Action on Oil Facilities During Violations

Updated Category News Views 267

South Coast AQMD Addresses Oil Site Violations In a determined effort to safeguard public health and air quality, the South Coast Air Quality Management District (South Coast AQMD) has recently taken enforcement action against three oil and gas facilities in Los Angeles. These actions were prompted by public complaints and confirmed violations of air quality regulations,...

Continue Reading
BAM UK & Ireland and LoadSpring Solutions Innovate Project Management

Updated Category News Views 199

BAM UK & Ireland and LoadSpring Solutions Innovate Project Management BAM UK & Ireland, a prominent name in the construction and engineering sector, has taken a bold step forward by partnering with LoadSpring Solutions. This collaboration aims to revolutionize project management through an innovative solution known as LoadSpring INSIGHTS™. This groundbreaking platform...

Continue Reading